Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
Neurocrine Biosciences Inc. (NBIX) is a commercial-stage biotechnology company focused on developing treatments for neurological, endocrine, and psychiatric disorders, trading at a current price of $128.52 as of April 6, 2026, marking a 2.34% decline from the previous close. This analysis outlines key technical levels, recent market context, and potential trading scenarios for NBIX, with no recent earnings data available for the company as of the publication date. The stock is currently trading
Will Neurocrine Biosciences (NBIX) Stock Hit Record Highs | Price at $128.52, Down 2.34% - Community Trade Ideas
NBIX - Stock Analysis
3016 Comments
1512 Likes
1
Loranna
Consistent User
2 hours ago
No thoughts, just vibes.
👍 18
Reply
2
Kevante
Trusted Reader
5 hours ago
Makes following the market a lot easier to understand.
👍 93
Reply
3
Inelda
Active Contributor
1 day ago
Indices continue to test intraday highs with moderate volume.
👍 45
Reply
4
Arkeshia
Loyal User
1 day ago
Anyone else been tracking this for a while?
👍 173
Reply
5
Bellamay
Experienced Member
2 days ago
US stock correlation matrix and portfolio risk analysis to understand how your holdings interact with each other. We help you identify concentration risks and provide recommendations for improving portfolio diversification.
👍 154
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.